Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors



Rating:

Share or cite this content

Citations should be made in the following way:
G. Barreto (Bad Nauheim, Germany). Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate. 2033

Member's Comments

No comment yet.

Related content which might interest you: Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Dermcidin identification from exhaled air for lung cancer diagnosis Source: Eur Respir J 2010; 35: 1182-1185 Year: 2010 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Attempt of detection of CYFRA 21-1 in exhaled breath condensate by patients with NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006 Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Structures of an exhaled breath condensate in lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 525s Year: 2005 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link? Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Human skin keratins are the major proteins in exhaled breath condensate Source: Eur Respir J 2008; 31: 380-384 Year: 2008 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015